血清免疫球蛋白和痴呆的生物标志物:一个基于人口的研究
Amber Yaqub1, Samer R Khan1,2, Meike W Vernooij1,3
1Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Alzheimer's research & therapy
|November 8, 2023
概括
这项研究在大量人群中没有发现血清免疫球蛋白与早期痴呆症生物标志物之间的显著联系. 未来的研究应该探索APOE-ε4载体和痴呆症发展中的性别差异.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 老年学是指老年学的学科.
背景情况:
- 炎症与痴呆症的发病因子有关.
- 血和神经成像中的早期痴呆症生物标志物与炎症没有很好的联系.
- 血清免疫球蛋白在早期痴呆症标志物的作用尚不清楚.
研究的目的:
- 研究血清免疫球蛋白 (IgA,IgG,IgM) 和痴呆症生物标志物之间的关联.
- 检查与等离子体标记物 (总tau,NfL,Aβ-40,Aβ-42) 和神经成像数据的关系.
- 探索基于APOE-ε4状态和性别的潜在差异.
主要方法:
- 在没有痴呆症的参与者身上测量的血清免疫球蛋白 (罗德丹研究,1997-2009年).
- 血生物标志物和神经成像数据被评估为子集.
- 用于分析横截面关联的线性回归模型,具有多重测试校正.
主要成果:
- 在多次测试校正后,血清免疫球蛋白和痴呆症生物标志物之间没有显著的关联.
- 暗示性联系:较高的IgA与较低的Aβ-42以及减少的大脑体积.
- 敏感性分析表明IgM与较低的t-tau,Aβ-40,Aβ-42和白质完整性的潜在关联.
结论:
- 在这个人群中,血清免疫球蛋白和早期痴呆症生物标志物之间没有发现强有力的关联.
- APOE-ε4等位基因的携带者和性别可能会影响这些关系.
- 对这些因素进行进一步调查是有必要的.
相关概念视频
01:30Dementia
120
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
120
01:26Alzheimer's Disease: Overview
498
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
498